LandisS., MurrayT., BoldenS.Cancer statistics, 1998. Ca Cancer J Clin.1998; 48: 6–29.
2.
HoeksemaM., LawC.Cancer mortality rates fall: a turning point for the nation. J Natl Cancer Inst.1996; 88: 1706–1707.
3.
CatalonaW., SmithD., WolfertR.Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA.1995; 274: 1214–1220.
4.
CatalonaW., RichieJ., AhmannF.Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter trial of 6,630 men. J Urol.1994; 151: 1283–1290.
5.
LabrieF., DupontA., CandasB.Decrease of prostate cancer death by screening: first data from the Quebec prospective and randomized study. Proc Annu Meet Am Soc Clin Oncol.1998; 17: 4. Abstract.
6.
JohanssonJ., HolmbergL., JohanssonS.Fifteen-year survival in prostate cancer: a prospective, population-based study in Sweden. JAMA.1997; 277: 467–471.
7.
GronbergH., DamberJ., JonssonH.Patient age as a prognostic factor in prostate cancer. J Urol.1994; 152: 892–895.
8.
AusG., PilebladE., HugossonJ.Impact in competing mortality on the cancer-related mortality in localized prostate cancer. Urology.1995; 46: 672–675.
9.
OhoriM., GoadJ., WheelerT.Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?J Urol.1994; 152: 1843–1849.
10.
RagdeH., ElgamalA., SnowP.Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer.1998; 83: 989–1001.
